학술논문
Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias
Document Type
Article
Author
Nikitin, E.; Kislova, M.; Shirokova, M.; Dmitrieva, E.; Kaplanov, K.; Ptushkin, V.; Poddubnaya, I.; Morozov, D.; Suvorova, A.; Makarovskaya, P.; Samoilova, O.; Belyakova, V.; Mayorova, O.; Sveshnikova, J.; Konstantinova, T.; Vyscub, G.; Matveeva, I.; Shipaeva, A.; Klitochenko, T.; Biderman, B.; Sudarikov, A.; Obukhova, T.
Source
In: Leukemia . (Leukemia, July 2023, 37(7):1464-1473)
Subject
Language
English
ISSN
14765551
08876924
08876924